Challenges in liver cancer and possible treatment approaches.

Globally, liver cancer is the most frequent fatal malignancy; in the United States, it ranks fifth. Patients are often diagnosed with liver cancer in advanced stages, contributing to its poor prognosis. Of all liver cancer cases, >90% are hepatocellular carcinomas (HCCs) for which chemotherapy and immunotherapy are the best options for therapy. For liver cancer patients, new treatment options are necessary. Use of natural compounds and/or nanotechnology may provide patients with better outcomes with lower systemic toxicity and fewer side effects. Improved treatments can lead to better prognoses. Finally, in this review, we present some of the problems and current treatment options contributing to the poor outcomes for patients with liver cancer.

[1]  John D. Roberts,et al.  Vorinostat and Sorafenib Synergistically Kill Tumor Cells via FLIP Suppression and CD95 Activation , 2008, Clinical Cancer Research.

[2]  K. Chin,et al.  The Biological Activities of Oleocanthal from a Molecular Perspective , 2018, Nutrients.

[3]  K. Hong,et al.  New Intra-arterial Drug Delivery System for the Treatment of Liver Cancer: Preclinical Assessment in a Rabbit Model of Liver Cancer , 2006, Clinical Cancer Research.

[4]  Ahmedin Jemal,et al.  International Trends in Liver Cancer Incidence Rates , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[5]  K. Srinivasan,et al.  Black Pepper and its Pungent Principle-Piperine: A Review of Diverse Physiological Effects , 2007, Critical reviews in food science and nutrition.

[6]  Na-Na He,et al.  The inhibition role of miR-22 in hepatocellular carcinoma cell migration and invasion via targeting CD147 , 2017, Cancer Cell International.

[7]  D. Strumberg,et al.  Combination of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma: results from a phase I extension trial. , 2009, European journal of cancer.

[8]  P. Sætrom,et al.  Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo , 2014, Hepatology.

[9]  Po-Huang Lee,et al.  Harnessing immunotherapy for liver recipients with hepatocellular carcinoma: a review from a transplant oncology perspective , 2019, Therapeutic advances in medical oncology.

[10]  Ying Cheng,et al.  Linifanib versus Sorafenib in patients with advanced hepatocellular carcinoma: results of a randomized phase III trial. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  M. Sawyer,et al.  Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  J. Lillard,et al.  Drug delivery approaches for breast cancer , 2017, International journal of nanomedicine.

[13]  Jennifer Couzin-Frankel,et al.  Breakthrough of the year 2013. Cancer immunotherapy. , 2013, Science.

[14]  Y. Shin,et al.  Sorafenib alone versus sorafenib combined with transarterial chemoembolization for advanced-stage hepatocellular carcinoma: results of propensity score analyses. , 2013, Radiology.

[15]  Thierry Boon,et al.  Human T cell responses against melanoma. , 2006, Annual review of immunology.

[16]  T. Kawaguchi,et al.  Expression of cyclooxygenase‐2 in human hepatocellular carcinoma: Relevance to tumor dedifferentiation , 1999, Hepatology.

[17]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[18]  Jae Ho Park,et al.  Protective effect of the extracts from Cnidium officinale against oxidative damage induced by hydrogen peroxide via antioxidant effect. , 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[19]  T. Andreassen,et al.  Anti-Cancer Potential of Homemade Fresh Garlic Extract Is Related to Increased Endoplasmic Reticulum Stress , 2018, Nutrients.

[20]  P. Ismail,et al.  In vitro Antiproliferative and Apoptosis Inducing Effect of Allium atroviolaceum Bulb Extract on Breast, Cervical, and Liver Cancer Cells , 2017, Front. Pharmacol..

[21]  Sung-Dae Cho,et al.  Effect of methanol extracts of Cnidium officinale Makino and Capsella bursa-pastoris on the apoptosis of HSC-2 human oral cancer cells , 2012, Experimental and therapeutic medicine.

[22]  G. Freeman,et al.  PD-1 and its ligands in tolerance and immunity. , 2008, Annual review of immunology.

[23]  C. Porta,et al.  Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial. , 2012, Journal of hepatology.

[24]  Yan Tang,et al.  Annexin A3 as a Potential Target for Immunotherapy of Liver Cancer Stem‐Like Cells , 2015, Stem cells.

[25]  Ying Sun,et al.  Juglanthraquinone C, a novel natural compound derived from Juglans mandshurica Maxim, induces S phase arrest and apoptosis in HepG2 cells , 2012, Apoptosis.

[26]  A. Mehta,et al.  Tivozanib: Status of Development , 2015, Current Oncology Reports.

[27]  Runping Liu,et al.  Natural products in licorice for the therapy of liver diseases: Progress and future opportunities. , 2019, Pharmacological research.

[28]  H. Gali-Muhtasib,et al.  Thymoquinone-based nanotechnology for cancer therapy: promises and challenges. , 2018, Drug discovery today.

[29]  K. Elangovan,et al.  Targeting hepatocellular carcinoma with piperine by radical-mediated mitochondrial pathway of apoptosis: An in vitro and in vivo study. , 2017, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[30]  W. L. Lumbera,et al.  Viscum Album Var Hot Water Extract Mediates Anti-cancer Effects through G1 Phase Cell Cycle Arrest in SK-Hep1 Human Hepatocarcinoma cells. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[31]  J. Coebergh,et al.  Increased consumption of fruit and vegetables and future cancer incidence in selected European countries. , 2010, European journal of cancer.

[32]  J. George,et al.  Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells , 2017, Molecular Cancer.

[33]  M. Kudo.  Immune Checkpoint Blockade in Hepatocellular Carcinoma: 2017 Update , 2016, Liver Cancer.

[34]  J. Lillard,et al.  Combinatorial effect of curcumin with docetaxel modulates apoptotic and cell survival molecules in prostate cancer. , 2017, Frontiers in bioscience.

[35]  T. Greten,et al.  Targets for immunotherapy of liver cancer. , 2017, Journal of hepatology.

[36]  M. Kudo,et al.  Effect of hepatic arterial infusion chemotherapy of 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma in the Nationwide Survey of Primary Liver Cancer in Japan , 2013, British Journal of Cancer.

[37]  J. Marrero,et al.  Diagnosis and treatment of hepatocellular carcinoma. , 2008, Gastroenterology.

[38]  S. Harrison,et al.  Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection , 2010, Hepatology.

[39]  M. Kudo.  Surveillance, Diagnosis, Treatment, and Outcome of Liver Cancer in Japan , 2015, Liver Cancer.

[40]  M. Bloomston,et al.  Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer , 2013, Nature Medicine.

[41]  Xiangliang Yang,et al.  Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer , 2014, International journal of nanomedicine.

[42]  R. Jain,et al.  Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal‐derived factor 1 alpha/C‐X‐C receptor type 4 axis and myeloid differentiation antigen–positive myeloid cell infiltration in mice , 2014, Hepatology.

[43]  Yinghui Zhou,et al.  Abstract A12: Variation in response to triple VEGFR inhibitor tivozanib in mouse models of hepatocellular carcinoma , 2009 .

[44]  Guo-Dong Yao,et al.  Phenylpropanoids from Juglans mandshurica exhibit cytotoxicities on liver cancer cell lines through apoptosis induction. , 2017, Bioorganic & medicinal chemistry letters.

[45]  Guo-Dong Yao,et al.  Alkaloids from Juglans Mandshurica maxim induce distinctive cell death in hepatocellular carcinoma cells , 2019, Natural product research.

[46]  J. Lillard,et al.  Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/ p21WAF1/CIP1 and p27KIP1 pathway , 2017, Oncotarget.

[47]  S. Coffelt,et al.  Revving Up Dendritic Cells while Braking PD-L1 to Jump-Start the Cancer-Immunity Cycle Motor. , 2016, Immunity.

[48]  P. Couvreur,et al.  Nanotechnology for therapy and imaging of liver diseases. , 2011, Journal of hepatology.

[49]  J. Lillard,et al.  Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer. , 2018, Cancer letters.

[50]  J. McCubrey,et al.  Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation. , 2017, International journal of oncology.

[51]  Dong Chen,et al.  In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy. , 2010, ACS nano.

[52]  Dieter Häussinger,et al.  Sorafenib in advanced hepatocellular carcinoma. , 2008, The New England journal of medicine.

[53]  A. Jemal,et al.  Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[54]  Yoon-Koo Kang,et al.  Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. , 2009, The Lancet. Oncology.

[55]  K. Kikuchi,et al.  Expression of PD-1, PD-L1, and PD-L2 in the Liver in Autoimmune Liver Diseases , 2007, The American Journal of Gastroenterology.

[56]  M. Saraswathy,et al.  Different strategies to overcome multidrug resistance in cancer. , 2013, Biotechnology advances.

[57]  D. Schadendorf,et al.  Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial. , 2018, The Lancet. Oncology.

[58]  Lei Chen,et al.  New knowledge of the mechanisms of sorafenib resistance in liver cancer , 2017, Acta Pharmacologica Sinica.

[59]  H. Glaeser,et al.  Piperine, a Major Constituent of Black Pepper, Inhibits Human P-glycoprotein and CYP3A4 , 2002, Journal of Pharmacology and Experimental Therapeutics.

[60]  S. Fan,et al.  A Garlic Derivative, S-allylcysteine (SAC), Suppresses Proliferation and Metastasis of Hepatocellular Carcinoma , 2012, PloS one.

[61]  S. Hwang,et al.  Anti cancer effects of Cnidium officinale Makino extract mediated through apoptosis and cell cycle arrest in the HT-29 human colorectal cancer cell line. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[62]  A. Bishayee.  The role of inflammation and liver cancer. , 2014, Advances in experimental medicine and biology.

[63]  Qing Xia,et al.  Silica nanoparticle-based dual-responsive nanoprodrug system for liver cancer therapy , 2017, Experimental and therapeutic medicine.

[64]  Wei Zhao,et al.  LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib-mediated death via inhibiting the AMPK–Mfn2 signaling pathway , 2019, Cancer Cell International.

[65]  B. Aggarwal,et al.  Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials , 2012, The AAPS Journal.

[66]  Tong Zhou,et al.  Dietary Natural Products for Prevention and Treatment of Liver Cancer , 2016, Nutrients.

[67]  Samit Ghosh,et al.  Allium vegetables in cancer prevention: an overview. , 2004, Asian Pacific journal of cancer prevention : APJCP.

[68]  D. Kirn,et al.  The emerging therapeutic potential of the oncolytic immunotherapeutic Pexa-Vec (JX-594) , 2015, Oncolytic virotherapy.

[69]  R. Finn,et al.  The Role of Angiogenesis in Hepatocellular Carcinoma , 2018, Clinical Cancer Research.

[70]  J. Singh,et al.  Piperine, a major ingredient of black and long peppers, protects against AFB1-induced cytotoxicity and micronuclei formation in H4IIEC3 rat hepatoma cells. , 1994, Cancer letters.

[71]  S. Qiu,et al.  Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcinoma , 2009, Clinical Cancer Research.

[72]  G. Zhu,et al.  Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity. , 2005, Cancer research.

[73]  R. Johri,et al.  Piperine-mediated changes in the permeability of rat intestinal epithelial cells. The status of gamma-glutamyl transpeptidase activity, uptake of amino acids and lipid peroxidation. , 1992, Biochemical pharmacology.

[74]  Damanpreet Singh,et al.  Synergistic effect of curcumin and piperine in suppression of DENA-induced hepatocellular carcinoma in rats. , 2015, Environmental toxicology and pharmacology.

[75]  S. Fogli,et al.  Oleocanthal and oleacein contribute to the in vitro therapeutic potential of extra virgin oil-derived extracts in non-melanoma skin cancer. , 2018, Toxicology in vitro : an international journal published in association with BIBRA.

[76]  Yoav D Livney,et al.  Rationally designed nanovehicles to overcome cancer chemoresistance. , 2013, Advanced drug delivery reviews.

[77]  R. Pazdur,et al.  Sorafenib for the treatment of unresectable hepatocellular carcinoma. , 2009, The oncologist.

[78]  Shangha Pan,et al.  (−)-Oleocanthal inhibits growth and metastasis by blocking activation of STAT3 in human hepatocellular carcinoma , 2016, Oncotarget.

[79]  Heeok Hong,et al.  Cnidium officinale Makino extract induces apoptosis through activation of caspase-3 and p53 in human liver cancer HepG2 cells. , 2017, Experimental and therapeutic medicine.

[80]  A. Mishra,et al.  Evidences for Piperine inhibiting cancer by targeting human G-quadruplex DNA sequences , 2016, Scientific Reports.

[81]  Kemin Wang,et al.  A novel fluorescent label based on organic dye-doped silica nanoparticles for HepG liver cancer cell recognition. , 2004, Journal of nanoscience and nanotechnology.

[82]  Kun Xu,et al.  Polysaccharides from Tricholoma matsutake and Lentinus edodes enhance 5-fluorouracil-mediated H22 cell growth inhibition. , 2014, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.

[83]  G. Sotiropoulos,et al.  Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[84]  B. Sangro,et al.  Immunotherapy of Hepatocellular Carcinoma: Facts and Hopes , 2017, Clinical Cancer Research.